MigraineMind research library

Latest Migraine & Headache Research

MigraineMind provides concise summaries, key learning points and links to the original scientific publications behind recently published migraine and headache research. Learn about MigraineMind or read how the research summaries are made.

Browse migraine research by topic

Explore focused collections that currently meet MigraineMind’s five-paper quality threshold.

443 research papers with stored summaries
  1. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

    The Lancet Neurology | 2017

    The study explored erenumab's safety and efficacy in chronic migraine patients. Researchers conducted a phase 2, randomized, double-blind trial across 69 centers in North America and Europe. Participants were adults…

  2. The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine

    Pain | 2017

    Calcitonin gene-related peptide, or CGRP, is a vital 37-amino acid peptide. It is mainly found in sensory fibers from the dorsal root and trigeminal ganglia. CGRP also exists in the central nervous system. This…

  3. Pathophysiology of Migraine: A Disorder of Sensory Processing

    Physiological Reviews | 2017

    Migraine affects over one billion people globally and is highly disabling. Its pathophysiology has evolved significantly from ancient theories to modern neurological understanding. Researchers consider three main…

  4. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine

    The Lancet Neurology | 2016

    Migraine affects women two to three times more than men. Women experience longer attacks and increased headache recurrence. They also report greater disability and longer recovery times. Comorbidities, such as…

  5. Chronic migraine: risk factors, mechanisms and treatment

    Nature Reviews Neurology | 2016

    Chronic migraine significantly impacts patients' lives, affecting their quality and socioeconomic functioning. It affects 1-2% of the general population and 8% of migraine patients. Chronic migraine usually develops…

  6. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine

    Nature Genetics | 2016

    Migraine affects about 14% of people globally and is quite debilitating. Its underlying causes remain unclear, sparking debate about vascular versus neuronal dysfunction. Previous studies found 13 loci linked to…

  7. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks

    Brain | 2016

    Recent research explored brain activity during migraines using advanced imaging techniques. Specifically, positron emission tomography and functional magnetic resonance imaging were utilized. The study identified a…

  8. Migraine: Multiple Processes, Complex Pathophysiology

    Journal of Neuroscience | 2015

    Migraine is a common, hereditary neurovascular headache disorder affecting many individuals. It often begins in childhood, increasing from a few times yearly to weekly in adulthood, especially in females. Migraine…

  9. The Acute Treatment of Migraine in Adults: The <scp>A</scp> merican <scp>H</scp> eadache <scp>S</scp> ociety Evidence Assessment of Migraine Pharmacotherapies

    Headache The Journal of Head and Face Pain | 2015

    This study reviews evidence for medications used to treat acute migraine attacks. It updates previous guidelines from the American Academy of Neurology published in 2000. A comprehensive literature search identified…

  10. Migraine Headache Triggered Specifically by Sunlight: Report of 16 Cases

    European Neurology | 2013

    Certain headaches arise from intracranial pathologies, like meningitis or tumors. These headaches result from mechanical or chemical stimulation of sensitive structures. Migraines, however, have an unknown origin and…

  11. Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain

    Pain | 2013

    Migraine involves inherited changes in brain excitability and pain pathways. The trigeminovascular pathway plays a key role in migraine development. Intracranial arterial dilation contributes to migraine symptoms as…

  12. Pathophysiology of Migraine

    Annual Review of Physiology | 2012

    Migraine is a complex neurological condition involving the brain and its tissues. Initially thought to be a blood vessel disorder, new evidence suggests otherwise. Migraine results from interactions within the…

  13. Vestibular migraine: Diagnostic criteria

    Journal of Vestibular Research | 2012

    This paper outlines the diagnostic criteria for vestibular migraine. These criteria were developed by the Bárány Society and the International Headache Society. The classification includes vestibular migraine and…

  14. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

    Neurology | 2012

    This research provides updated recommendations for preventing migraine headaches. The authors aimed to identify effective pharmacologic therapies for migraine prevention. They analyzed studies published from June…

  15. Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain Injury

    Journal of Cerebral Blood Flow & Metabolism | 2010

    Cortical spreading depression (CSD) is linked to brain ion homeostasis failure. It leads to the release of excitatory amino acids from nerve cells. CSD is associated with increased energy metabolism and changes in…

  16. Prevalence of headache and migraine in children and adolescents: a systematic review of population‐based studies

    Developmental Medicine & Child Neurology | 2010

    This study reviews the prevalence of headache and migraine in children and adolescents. Researchers analyzed 50 population-based studies conducted from 1990 to 2007. The estimated prevalence of headache in this group…

  17. Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

    Cephalalgia | 2010

    Migraine significantly impacts patients, families, and health care systems worldwide. This study compared chronic migraine (CM) and episodic migraine (EM) sufferers' experiences. Researchers wanted to see if migraine…

  18. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

    Cephalalgia | 2010

    This study investigates the effectiveness of onabotulinumtoxinA for chronic migraine treatment. It is part of the PREEMPT 1 trial, focused on safety and efficacy. The study lasted 24 weeks and included a…

  19. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

    Headache The Journal of Head and Face Pain | 2010

    This research investigates onabotulinumtoxinA, commonly known as BOTOX, for chronic migraine treatment. Chronic migraine is a common, debilitating condition that often remains untreated. The study pooled results from…

  20. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

    Journal of Neurology Neurosurgery & Psychiatry | 2010

    This research aimed to compare the sociodemographic profiles of chronic migraine and episodic migraine sufferers. The study analyzed data from the AMPP survey, which included 24,000 headache sufferers. Among them…